Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease. (Q46622922)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Anton Forsberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Agneta Nordberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

6

B Långström

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

E Stefanova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

A Wall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

A Nilsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

29 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

205-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00702-005-0312-6

4 January 2020

exact match

0 references

cites work

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0312-6

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0312-6

Comparing functional (PET) images: the assessment of significant change

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0312-6

Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0312-6

Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0312-6

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0312-6

Orbital and Dorsolateral Frontal Perfusion Defect Associated With Behavioral Response to Cholinesterase Inhibitor Therapy in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0312-6

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0312-6

A computerized brain atlas: construction, anatomical content, and some applications

21 January 2018

1 reference

12 December 2020

Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography

1 reference

12 December 2020

Episodic memory functioning in a community-based sample of old adults with major depression: utilization of cognitive support.

1 reference

12 December 2020

Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease

1 reference

12 December 2020

CBA--an atlas-based software tool used to facilitate the interpretation of neuroimaging data

1 reference

12 December 2020

Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping.

1 reference

12 December 2020

1 reference

12 December 2020

Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients.

1 reference

12 December 2020

Cerebral pharmacodynamics of physostigmine in Alzheimer's disease investigated using single-photon computerised tomography.

1 reference

12 December 2020

Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer's disease

1 reference

12 December 2020

Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease

1 reference

12 December 2020

Impairment of neocortical metabolism predicts progression in Alzheimer's disease.

1 reference

12 December 2020

Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study

1 reference

12 December 2020

1 reference

12 December 2020

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

1 reference

12 December 2020

Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease

1 reference

12 December 2020

How to estimate global activity independent of changes in local activity.

1 reference

12 December 2020

In vivo brain incorporation of [1-14C]arachidonate in awake rats, with or without cholinergic stimulation, following unilateral lesioning of nucleus basalis magnocellularis

1 reference

12 December 2020

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

1 reference

12 December 2020

Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease

1 reference

12 December 2020

Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease

1 reference

12 December 2020

Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease

1 reference

12 December 2020

Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease.

1 reference

12 December 2020

Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.

1 reference

12 December 2020

Implementation and validation of a fully automatic system for intra- and interindividual registration of PET brain scans.

1 reference

12 December 2020

A 12-month study of the efficacy of rivastigmine in patients with advanced moderate Alzheimer's disease

1 reference

12 December 2020

Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease.

1 reference

12 December 2020

Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients

1 reference

12 December 2020

10.1007/S00702-005-0312-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16049637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference